CASC15 and neoplasm: Another study reported that lncRNA cancer susceptibility 15 (CASC15) is upregulated in OS plasma exosomes, and knockdown of CASC15 has been found to impede tumor growth both in vitro and in vivo by targeting the miR-338-3p/RAB14 axis [77].